文献速递腹部技术与安全US

代谢功能障碍相关脂肪性肝病中的超声标志物与小叶炎症、脂肪变性和纤维化:iLEAD研究

US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
PubMed 文献 · Radiology · 2024-01-01

这项国际多中心前瞻性研究纳入124例活检证实的MASLD患者,评估剪切波色散斜率(DS)、衰减系数(AC)和剪切波速度(SWS)与病理坏死性炎症的关系。DS与病理小叶炎症分级独立相关,鉴别中重度小叶炎症的AUC为0.72;AC和SWS分别对脂肪变和纤维化诊断性能优良。

要点

  • DS与病理小叶炎症分级独立相关,鉴别中重度炎症(A2及以上)AUC为0.72。
  • AC鉴别轻度及以上脂肪变(S1及以上)AUC为0.92,SWS鉴别临床显著纤维化(F2及以上)AUC为0.91。
  • 三种标志物中,SWS诊断代谢功能障碍相关脂肪性肝炎的AUC最高(0.81)。

核心结论

  • 在DS、AC和SWS三种超声影像标志物中,DS与组织学小叶炎症分级相关性最强,鉴别中重度小叶炎症的诊断性能尚可。

研究设计与样本

  • 国际多中心前瞻性研究,2019年6月至2023年3月连续纳入124例活检证实的MASLD患者,活检前行多参数超声测量DS、AC和SWS,以组织病理学为参考标准。

诊断标准与关键数值

  • DS鉴别炎症分级A2及以上(中重度炎症)的AUC为0.72(95%CI:0.63,0.82)。
  • AC鉴别脂肪变分级S1及以上(轻度)的AUC为0.92(95%CI:0.87,0.97)。
  • SWS鉴别纤维化分期F2及以上(临床显著纤维化)的AUC为0.91(95%CI:0.86,0.96)。
  • 三种标志物中,SWS诊断代谢功能障碍相关脂肪性肝炎的AUC最高,为0.81(95%CI:0.74,0.89)。

临床应用与阅片要点

  • 多参数超声可同时评估MASLD患者的脂肪变(AC)、纤维化(SWS)和炎症(DS),DS为评估小叶炎症提供了新的无创指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Attenuation coefficient (AC) and shear-wave speed (SWS) are established US markers for assessing patients with metabolic dysfunction-associated steatotic liver disease (MASLD), while shear-wave dispersion slope (DS) is not. Purpose To assess the relationship between the multiparametric US imaging markers DS, AC, and SWS and liver histopathologic necroinflammation in patients with MASLD. Materials and Methods This international multicenter prospective study enrolled consecutive patients with biopsy-proven MASLD between June 2019 and March 2023. Before biopsy, all participants underwent multiparametric US, and measurements of DS, AC, and SWS were obtained. Multivariable linear regression analyses were performed to assess the association of clinical variables and imaging markers with pathologic findings. The diagnostic performance of imaging markers for determining inflammation grade, steatosis grade, and fibrosis stage was assessed using the area under the receiver operating characteristic curve (AUC). Results A total of 124 participants (mean age, 53 years ± 15 [SD]; 62 males) were evaluated. In multivariable regression, lobular inflammation was associated with DS (regression coefficient, 0.06; P = .02), alanine aminotransferase level (regression coefficient, 0.002; P = .002), and Hispanic or Latino ethnicity (regression coefficient, -0.68; P = .047), while steatosis was associated with AC (regression coefficient, 3.66; P < .001) and fibrosis was associated with SWS (regression coefficient, 2.02; P < .001) and body mass index (regression coefficient, 0.05; P = .02). DS achieved an AUC of 0.72 (95% CI: 0.63, 0.82) for identifying participants with inflammation grade A2 or higher (moderate to severe inflammation). AC showed excellent performance for identifying participants with grade S1 (mild) or higher steatosis (AUC, 0.92 [95% CI: 0.87, 0.97]), while SWS showed excellent performance for identifying participants with fibrosis stage F2 or higher (clinically significant fibrosis) (AUC, 0.91 [95% CI: 0.86, 0.96]). Of the three US markers, SWS showed the highest AUC (0.81 [95% CI: 0.74, 0.89]) for the diagnosis of metabolic dysfunction-associated steatohepatitis. Conclusion Of the three US imaging markers (DS, AC, and SWS), DS was most associated with lobular inflammation grade at histologic examination and demonstrated fair diagnostic performance in distinguishing moderate to severe lobular inflammation. ClinicalTrials.gov Identifier: NCT04012242 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Yin in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Sugimoto K, Moriyasu F, Dioguardi Burgio M, et al. US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study. Radiology. 2024. PMID: 39162633. doi:10.1148/radiol.233377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。